Additionally, eicosapentaenoic acid (EPA) inhibits the DNA‐PKcs/AKT and DNA‐PKcs/PD‐L1 pathways, thereby enhancing the therapeutic impact of DDP in osteosarcoma.29 This evidence concerns the gene PRKDC and osteosarcoma.